netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
Chapter Links...
 Details...
04.07.01  Expand sub section  Non-opioid analgesics and compound analgesic preparations
04.07.01  Expand sub section  Compound analgesic preparations
Aspirin
(Analgesic)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Chronic intractable daily headache (Aspirin 500mg injection - unlicensed - Restricted to neurology)
    • Mild to moderate pain
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
   
Co-codamol 30/500 (Paracetamol + Codeine)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
   
Co-codamol 8/500 (Paracetamol + Codeine)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
   
Co-dydramol 10/500 (Paracetamol + Dihydrocodeine)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Nefopam
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Paracetamol IV
(Pain)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • To be kept in restricted areas such as theatres and ICU
    • All patients on intravenous paracetamol must be reviewed every 24 hours so that an alternative route should be used as soon as possible.
    • Patients requiring Paracetamol IV outside the ICU or theatres must be referred to the pain team first.
  • RFL:
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • The use of intravenous paracetamol is reserved for paediatric and oncology patients or adult patients on the recommendation of a consultant anaesthetist or the acute pain team
 
   
Paracetamol oral
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • More than 95% of a dose of paracetamol is absorbed when given orally, and there is no evidence that giving paracetamol intravenously is more effective than giving it orally
 
   
 ....
 Non Formulary Items
Co-codamol 15/500  (Paracetamol + Codeine)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Co-codaprin  (Aspirin + Codeine)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Co-dydramol 20/500  (Paracetamol + Dihydrocodeine)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Co-dydramol 30/500  (Paracetamol + Dihydrocodeine)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Co-proxamol

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for chronic pain (September 2017)

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.  

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary